RPS6KB1 and cancer: PSD acts as an autophagy flux inhibitor in various cancer cells and induces autophagosome initiation; it can serve as a chemosensitizer, where its inhibition of mTOR and phosphorylation of its downstream target p70S6K induces autophagosome formation [37].